Change of Company Secretary MELBOURNE Australia, 23 October 2026 – Prescient Therapeutics (ASX: PTX), a clinical-stage oncology company developing targeted cancer therapies, is pleased to announce the appointment of Ms Mariia Skorikova and Mr Tony Di Pietro as joint Company Secretaries effective...
Change of Company Secretary
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Prescient Therapeutics Limited has announced a change in its Company Secretary, appointing Ms. Mariia Skorikova and Mr. Tony Di Pietro as joint Company Secretaries, effective immediately. The Board expressed gratitude for Melanie's contributions and welcomed the new appointees, highlighting their extensive experience in corporate governance and accounting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- Results of Annual General Meeting
- Chair Address and CEO AGM Presentation
- September 2026 Quarterly Update and Appendix 4C
- Change of Director's Interest Notice
- Notification regarding unquoted securities - PTX
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics